Rhumbline Advisers lifted its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 16.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 343,590 shares of the semiconductor company’s stock after acquiring an additional 49,339 shares during the period. Rhumbline Advisers owned 0.18% of Synopsys worth $169,524,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in Synopsys by 1.6% in the second quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock worth $7,721,363,000 after acquiring an additional 231,014 shares in the last quarter. State Street Corp raised its holdings in shares of Synopsys by 1.2% in the 2nd quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock worth $3,725,362,000 after purchasing an additional 85,662 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Synopsys by 1.5% during the second quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock worth $1,810,214,000 after purchasing an additional 51,043 shares during the period. Ameriprise Financial Inc. increased its position in shares of Synopsys by 29.1% in the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after acquiring an additional 585,494 shares in the last quarter. Finally, Alliancebernstein L.P. lifted its holdings in shares of Synopsys by 10.9% in the second quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock valued at $980,757,000 after purchasing an additional 187,790 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have weighed in on SNPS. Morgan Stanley lifted their target price on Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Rosenblatt Securities raised shares of Synopsys from a “neutral” rating to a “buy” rating and cut their target price for the stock from $605.00 to $560.00 in a research report on Tuesday, December 9th. Bank of America raised Synopsys from an “underperform” rating to a “neutral” rating and cut their price target for the company from $525.00 to $500.00 in a report on Monday, December 8th. Needham & Company LLC increased their target price on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Finally, JPMorgan Chase & Co. lifted their target price on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Synopsys currently has a consensus rating of “Moderate Buy” and a consensus price target of $553.57.
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $438.21 on Thursday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The firm’s 50-day simple moving average is $478.54 and its 200 day simple moving average is $492.32. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. The stock has a market cap of $83.84 billion, a price-to-earnings ratio of 54.84, a PEG ratio of 3.64 and a beta of 1.12.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same period last year, the business posted $3.40 earnings per share. The business’s revenue for the quarter was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, research analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 4,157 shares of company stock valued at $1,945,036. 0.62% of the stock is owned by corporate insiders.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Is THIS the Next Big Money Rush?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- They just tried to kill gold
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
